Search - tctmd.com

Displaying 301 - 320 of 374

Sort: Relevancy | Date

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Daily News

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Yael L. Maxwell

December 13, 2012

News Daily News

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Yael L. Maxwell

December 13, 2012

News Industry News

Significantly Better Patient Outcomes Gained from Pacing Both Ventricles in Patients with AV Block and Reduced Pumping Function

November 05, 2012

News Industry News

FDA expands approved use of Sapien artificial heart valve

October 19, 2012

News Daily News

Aggressive Strategy Improves Short-term Survival of Comatose Cardiac Arrest Patients

September 25, 2012

News Industry News

Medtronic Announces First Patient Enrollment in Global Heart Rhythm Study

September 20, 2012

News Industry News

Landmark IMPROVE HF Trial Shows Evidence-Based Programs Result in Improvements in Heart Failure Patients Regardless of Race, and Improves Survival

August 30, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Industry News

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

August 26, 2012

News Industry News

St. Jude Medical Announces Japanese Launch of Industry's First Small Quadripolar Technology to Treat Heart Failure

July 17, 2012

News Industry News

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

July 02, 2012

News Daily News

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

Caitlin E. Cox

June 21, 2012

News Industry News

Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer

June 13, 2012

News Industry News

CardioFocus Announces Largest Worldwide Study of HeartLight® EAS Acute Clinical Outcomes Presented at Heart Rhythm 2012

June 04, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

June 01, 2012

News Daily News

Un Documento de Consenso Perfila las Directrices para el Uso del Cateterismo Cardíaco

May 15, 2012

News Daily News

Consensus Document Outlines Guidelines for Cardiac Cath Use

May 15, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

Advertisement

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Significantly Better Patient Outcomes Gained from Pacing Both Ventricles in Patients with AV Block and Reduced Pumping Function

FDA expands approved use of Sapien artificial heart valve

Aggressive Strategy Improves Short-term Survival of Comatose Cardiac Arrest Patients

Medtronic Announces First Patient Enrollment in Global Heart Rhythm Study

Landmark IMPROVE HF Trial Shows Evidence-Based Programs Result in Improvements in Heart Failure Patients Regardless of Race, and Improves Survival

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

St. Jude Medical Announces Japanese Launch of Industry's First Small Quadripolar Technology to Treat Heart Failure

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer

CardioFocus Announces Largest Worldwide Study of HeartLight® EAS Acute Clinical Outcomes Presented at Heart Rhythm 2012

Watchman Works Just as Well Without Warfarin-Protected Transition

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

Un Documento de Consenso Perfila las Directrices para el Uso del Cateterismo Cardíaco

Consensus Document Outlines Guidelines for Cardiac Cath Use

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content